Does it not concern you that KCH, in 2015, after years of recruiting trial patients with ‘GBM4’, should make such a prognosticative error, because, if they were putting patients forward that had, in reality, a more than a fair chance of long term survival without the vaccine, do you not see how that patient selection could bias the results ?
In some context, it matters not the diagnosis nor ‘2 weeks to live’, statement rather the rights of a patient to give informed consent to any and all treatment. And to be fully made aware of any risks involved of said treatment.
Especially when that treatment is applied under the false premise of an histologically unfounded statement about my imminent demise by the clinical trial patient procurement nurse.
Further, before I sacked the Oncologist, he did arrange for the Hospice to attend my home to initiate immediate end of life palliative care, when I told him there had been a mistake.
He simply stated that I was in denial about my imminent death, and that I must complete all the further treatment.
The hospice, in my home, told me that I needed to tell my children that I was going to die soon !!
There is also a massive amount of evidence the NICE & MHRA have, so to be frank, I do not give a damn about whether whether you can fill your pockets with silver, off the bones of previous gbm4 patients who sadly passed away.
You speculators, are beyond contempt.
That’s why I insisted on a fresh scan after 6 weeks weeks of chemo /radiation
This is hardly indicative of a well oiled gbm4 diagnostic machine, is it ?
That is a wholly rational position for a former patient to take, as opposed to yours,?which is purely driven by greed as a shareholder.
Market Data 
Markets 
AI
